nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—Aspartame—Bortezomib—hematologic cancer	0.592	1	CrCrCtD
Quinapril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSZ—hematologic cancer	0.0048	0.158	CbGpPWpGaD
Quinapril—ACE—Metabolism of Angiotensinogen to Angiotensins—ANPEP—hematologic cancer	0.0048	0.158	CbGpPWpGaD
Quinapril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—hematologic cancer	0.00237	0.0781	CbGpPWpGaD
Quinapril—ACE—Metabolism of Angiotensinogen to Angiotensins—CMA1—hematologic cancer	0.00234	0.0772	CbGpPWpGaD
Quinapril—ACE—ACE Inhibitor Pathway—CMA1—hematologic cancer	0.00223	0.0735	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—CTSZ—hematologic cancer	0.00126	0.0415	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—ANPEP—hematologic cancer	0.00126	0.0415	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—MME—hematologic cancer	0.000623	0.0205	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—CMA1—hematologic cancer	0.000616	0.0203	CbGpPWpGaD
Quinapril—Benazepril—MTHFR—hematologic cancer	0.000521	0.356	CrCbGaD
Quinapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hematologic cancer	0.000487	0.016	CbGpPWpGaD
Quinapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hematologic cancer	0.000452	0.0149	CbGpPWpGaD
Quinapril—ACE—ACE Inhibitor Pathway—TGFB1—hematologic cancer	0.00045	0.0148	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—LDHD—hematologic cancer	0.00037	0.0122	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—GCNT4—hematologic cancer	0.00028	0.00923	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000244	0.00803	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—CTSZ—hematologic cancer	0.000238	0.00784	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—ANPEP—hematologic cancer	0.000238	0.00784	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000227	0.00746	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—DPM1—hematologic cancer	0.000224	0.00738	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—ASNS—hematologic cancer	0.000224	0.00738	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000218	0.00716	CbGpPWpGaD
Quinapril—Perindopril—ABCB1—hematologic cancer	0.000217	0.148	CrCbGaD
Quinapril—ACE—Metabolism of proteins—PREB—hematologic cancer	0.000203	0.00667	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000202	0.00665	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—GCNT1—hematologic cancer	0.000194	0.00639	CbGpPWpGaD
Quinapril—Lisinopril—ABCB1—hematologic cancer	0.000191	0.13	CrCbGaD
Quinapril—Cilazapril—ABCB1—hematologic cancer	0.000191	0.13	CrCbGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000176	0.00579	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—MUC1—hematologic cancer	0.000165	0.00544	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000164	0.00539	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000163	0.00538	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000152	0.005	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—RPLP1—hematologic cancer	0.000144	0.00475	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000144	0.00474	CbGpPWpGaD
Quinapril—Enalapril—ABCB1—hematologic cancer	0.00014	0.0957	CrCbGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000136	0.00447	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000134	0.00439	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000133	0.00439	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—TUBB2A—hematologic cancer	0.000133	0.00436	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000131	0.00431	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000126	0.00415	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000124	0.00408	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000124	0.00408	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000121	0.004	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—MME—hematologic cancer	0.000118	0.00387	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000117	0.00384	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—SUMO1—hematologic cancer	0.000116	0.00383	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—CMA1—hematologic cancer	0.000116	0.00383	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000115	0.00379	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—SPHK1—hematologic cancer	0.000114	0.00375	CbGpPWpGaD
Quinapril—Propafenone—ABCB1—hematologic cancer	0.000113	0.0768	CrCbGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000111	0.00364	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000108	0.00356	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000103	0.00338	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—RPS14—hematologic cancer	0.000102	0.00336	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000101	0.00333	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000101	0.00333	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000101	0.00333	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	9.38e-05	0.00309	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	9.38e-05	0.00309	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	9.38e-05	0.00309	CbGpPWpGaD
Quinapril—Fentanyl—ABCB1—hematologic cancer	9.23e-05	0.063	CrCbGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	9.1e-05	0.003	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—EIF4EBP1—hematologic cancer	8.92e-05	0.00294	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	8.45e-05	0.00278	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—HSPA5—hematologic cancer	8.25e-05	0.00272	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—CALR—hematologic cancer	8e-05	0.00263	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	7.99e-05	0.00263	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—FBXW7—hematologic cancer	7.73e-05	0.00255	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	7.42e-05	0.00244	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	7.31e-05	0.00241	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	6.9e-05	0.00227	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	6.78e-05	0.00223	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.7e-05	0.0022	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.65e-05	0.00219	CbGpPWpGaD
Quinapril—Diarrhoea—Cisplatin—hematologic cancer	6.65e-05	0.000176	CcSEcCtD
Quinapril—Alopecia—Methotrexate—hematologic cancer	6.63e-05	0.000176	CcSEcCtD
Quinapril—Vomiting—Gemcitabine—hematologic cancer	6.63e-05	0.000176	CcSEcCtD
Quinapril—Insomnia—Betamethasone—hematologic cancer	6.62e-05	0.000176	CcSEcCtD
Quinapril—Insomnia—Dexamethasone—hematologic cancer	6.62e-05	0.000176	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.61e-05	0.000175	CcSEcCtD
Quinapril—Paraesthesia—Dexamethasone—hematologic cancer	6.58e-05	0.000175	CcSEcCtD
Quinapril—Paraesthesia—Betamethasone—hematologic cancer	6.58e-05	0.000175	CcSEcCtD
Quinapril—Discomfort—Prednisone—hematologic cancer	6.57e-05	0.000175	CcSEcCtD
Quinapril—Mental disorder—Methotrexate—hematologic cancer	6.57e-05	0.000175	CcSEcCtD
Quinapril—Rash—Gemcitabine—hematologic cancer	6.57e-05	0.000174	CcSEcCtD
Quinapril—Dermatitis—Gemcitabine—hematologic cancer	6.57e-05	0.000174	CcSEcCtD
Quinapril—Eye disorder—Epirubicin—hematologic cancer	6.56e-05	0.000174	CcSEcCtD
Quinapril—Headache—Gemcitabine—hematologic cancer	6.53e-05	0.000173	CcSEcCtD
Quinapril—Nausea—Vincristine—hematologic cancer	6.53e-05	0.000173	CcSEcCtD
Quinapril—Cardiac disorder—Epirubicin—hematologic cancer	6.52e-05	0.000173	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.52e-05	0.00214	CbGpPWpGaD
Quinapril—Hepatitis—Doxorubicin—hematologic cancer	6.5e-05	0.000172	CcSEcCtD
Quinapril—Pharyngitis—Doxorubicin—hematologic cancer	6.45e-05	0.000171	CcSEcCtD
Quinapril—Dyspepsia—Betamethasone—hematologic cancer	6.45e-05	0.000171	CcSEcCtD
Quinapril—Dyspepsia—Dexamethasone—hematologic cancer	6.45e-05	0.000171	CcSEcCtD
Quinapril—Urinary tract disorder—Doxorubicin—hematologic cancer	6.42e-05	0.00017	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	6.4e-05	0.00211	CbGpPWpGaD
Quinapril—Asthenia—Etoposide—hematologic cancer	6.39e-05	0.00017	CcSEcCtD
Quinapril—Connective tissue disorder—Doxorubicin—hematologic cancer	6.38e-05	0.00017	CcSEcCtD
Quinapril—Anaphylactic shock—Prednisone—hematologic cancer	6.38e-05	0.000169	CcSEcCtD
Quinapril—Oedema—Prednisone—hematologic cancer	6.38e-05	0.000169	CcSEcCtD
Quinapril—Angiopathy—Epirubicin—hematologic cancer	6.37e-05	0.000169	CcSEcCtD
Quinapril—Urethral disorder—Doxorubicin—hematologic cancer	6.37e-05	0.000169	CcSEcCtD
Quinapril—Nausea—Mitoxantrone—hematologic cancer	6.36e-05	0.000169	CcSEcCtD
Quinapril—Nausea—Irinotecan—hematologic cancer	6.36e-05	0.000169	CcSEcCtD
Quinapril—Immune system disorder—Epirubicin—hematologic cancer	6.34e-05	0.000168	CcSEcCtD
Quinapril—Infection—Prednisone—hematologic cancer	6.34e-05	0.000168	CcSEcCtD
Quinapril—Mediastinal disorder—Epirubicin—hematologic cancer	6.33e-05	0.000168	CcSEcCtD
Quinapril—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.32e-05	0.000168	CcSEcCtD
Quinapril—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.32e-05	0.000168	CcSEcCtD
Quinapril—Back pain—Methotrexate—hematologic cancer	6.32e-05	0.000168	CcSEcCtD
Quinapril—Fatigue—Dexamethasone—hematologic cancer	6.31e-05	0.000168	CcSEcCtD
Quinapril—Fatigue—Betamethasone—hematologic cancer	6.31e-05	0.000168	CcSEcCtD
Quinapril—Pruritus—Etoposide—hematologic cancer	6.3e-05	0.000167	CcSEcCtD
Quinapril—Shock—Prednisone—hematologic cancer	6.28e-05	0.000167	CcSEcCtD
Quinapril—Arrhythmia—Epirubicin—hematologic cancer	6.27e-05	0.000167	CcSEcCtD
Quinapril—Nervous system disorder—Prednisone—hematologic cancer	6.26e-05	0.000166	CcSEcCtD
Quinapril—Tachycardia—Prednisone—hematologic cancer	6.23e-05	0.000165	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.22e-05	0.00205	CbGpPWpGaD
Quinapril—Alopecia—Epirubicin—hematologic cancer	6.21e-05	0.000165	CcSEcCtD
Quinapril—Skin disorder—Prednisone—hematologic cancer	6.2e-05	0.000164	CcSEcCtD
Quinapril—Nausea—Gemcitabine—hematologic cancer	6.19e-05	0.000164	CcSEcCtD
Quinapril—Vomiting—Cisplatin—hematologic cancer	6.18e-05	0.000164	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.17e-05	0.00203	CbGpPWpGaD
Quinapril—Hyperhidrosis—Prednisone—hematologic cancer	6.17e-05	0.000164	CcSEcCtD
Quinapril—Mental disorder—Epirubicin—hematologic cancer	6.15e-05	0.000163	CcSEcCtD
Quinapril—Rash—Cisplatin—hematologic cancer	6.13e-05	0.000163	CcSEcCtD
Quinapril—Dermatitis—Cisplatin—hematologic cancer	6.12e-05	0.000162	CcSEcCtD
Quinapril—Diarrhoea—Etoposide—hematologic cancer	6.09e-05	0.000162	CcSEcCtD
Quinapril—Eye disorder—Doxorubicin—hematologic cancer	6.07e-05	0.000161	CcSEcCtD
Quinapril—Ill-defined disorder—Methotrexate—hematologic cancer	6.06e-05	0.000161	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.05e-05	0.00199	CbGpPWpGaD
Quinapril—Feeling abnormal—Betamethasone—hematologic cancer	6.04e-05	0.00016	CcSEcCtD
Quinapril—Feeling abnormal—Dexamethasone—hematologic cancer	6.04e-05	0.00016	CcSEcCtD
Quinapril—Cardiac disorder—Doxorubicin—hematologic cancer	6.03e-05	0.00016	CcSEcCtD
Quinapril—Flatulence—Epirubicin—hematologic cancer	6.02e-05	0.00016	CcSEcCtD
Quinapril—Tension—Epirubicin—hematologic cancer	6e-05	0.000159	CcSEcCtD
Quinapril—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.99e-05	0.000159	CcSEcCtD
Quinapril—Gastrointestinal pain—Betamethasone—hematologic cancer	5.99e-05	0.000159	CcSEcCtD
Quinapril—Nervousness—Epirubicin—hematologic cancer	5.94e-05	0.000158	CcSEcCtD
Quinapril—Back pain—Epirubicin—hematologic cancer	5.91e-05	0.000157	CcSEcCtD
Quinapril—Angiopathy—Doxorubicin—hematologic cancer	5.89e-05	0.000156	CcSEcCtD
Quinapril—Malaise—Methotrexate—hematologic cancer	5.89e-05	0.000156	CcSEcCtD
Quinapril—Dizziness—Etoposide—hematologic cancer	5.89e-05	0.000156	CcSEcCtD
Quinapril—Immune system disorder—Doxorubicin—hematologic cancer	5.87e-05	0.000156	CcSEcCtD
Quinapril—Vertigo—Methotrexate—hematologic cancer	5.87e-05	0.000156	CcSEcCtD
Quinapril—Mediastinal disorder—Doxorubicin—hematologic cancer	5.86e-05	0.000155	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.81e-05	0.000154	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.81e-05	0.00191	CbGpPWpGaD
Quinapril—Dizziness—Prednisolone—hematologic cancer	5.8e-05	0.000154	CcSEcCtD
Quinapril—Arrhythmia—Doxorubicin—hematologic cancer	5.8e-05	0.000154	CcSEcCtD
Quinapril—Asthenia—Triamcinolone—hematologic cancer	5.79e-05	0.000154	CcSEcCtD
Quinapril—Abdominal pain—Betamethasone—hematologic cancer	5.79e-05	0.000154	CcSEcCtD
Quinapril—Abdominal pain—Dexamethasone—hematologic cancer	5.79e-05	0.000154	CcSEcCtD
Quinapril—Nausea—Cisplatin—hematologic cancer	5.77e-05	0.000153	CcSEcCtD
Quinapril—Insomnia—Prednisone—hematologic cancer	5.77e-05	0.000153	CcSEcCtD
Quinapril—Alopecia—Doxorubicin—hematologic cancer	5.74e-05	0.000152	CcSEcCtD
Quinapril—Paraesthesia—Prednisone—hematologic cancer	5.73e-05	0.000152	CcSEcCtD
Quinapril—Pruritus—Triamcinolone—hematologic cancer	5.71e-05	0.000152	CcSEcCtD
Quinapril—Cough—Methotrexate—hematologic cancer	5.7e-05	0.000151	CcSEcCtD
Quinapril—Mental disorder—Doxorubicin—hematologic cancer	5.69e-05	0.000151	CcSEcCtD
Quinapril—Ill-defined disorder—Epirubicin—hematologic cancer	5.67e-05	0.000151	CcSEcCtD
Quinapril—Vomiting—Etoposide—hematologic cancer	5.66e-05	0.00015	CcSEcCtD
Quinapril—Dyspepsia—Prednisone—hematologic cancer	5.62e-05	0.000149	CcSEcCtD
Quinapril—Rash—Etoposide—hematologic cancer	5.61e-05	0.000149	CcSEcCtD
Quinapril—Dermatitis—Etoposide—hematologic cancer	5.61e-05	0.000149	CcSEcCtD
Quinapril—Headache—Etoposide—hematologic cancer	5.58e-05	0.000148	CcSEcCtD
Quinapril—Flatulence—Doxorubicin—hematologic cancer	5.57e-05	0.000148	CcSEcCtD
Quinapril—Arthralgia—Methotrexate—hematologic cancer	5.56e-05	0.000148	CcSEcCtD
Quinapril—Chest pain—Methotrexate—hematologic cancer	5.56e-05	0.000148	CcSEcCtD
Quinapril—Myalgia—Methotrexate—hematologic cancer	5.56e-05	0.000148	CcSEcCtD
Quinapril—Tension—Doxorubicin—hematologic cancer	5.55e-05	0.000147	CcSEcCtD
Quinapril—Rash—Prednisolone—hematologic cancer	5.53e-05	0.000147	CcSEcCtD
Quinapril—Dermatitis—Prednisolone—hematologic cancer	5.53e-05	0.000147	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.52e-05	0.000147	CcSEcCtD
Quinapril—Malaise—Epirubicin—hematologic cancer	5.51e-05	0.000146	CcSEcCtD
Quinapril—Fatigue—Prednisone—hematologic cancer	5.5e-05	0.000146	CcSEcCtD
Quinapril—Headache—Prednisolone—hematologic cancer	5.5e-05	0.000146	CcSEcCtD
Quinapril—Discomfort—Methotrexate—hematologic cancer	5.49e-05	0.000146	CcSEcCtD
Quinapril—Nervousness—Doxorubicin—hematologic cancer	5.49e-05	0.000146	CcSEcCtD
Quinapril—Vertigo—Epirubicin—hematologic cancer	5.49e-05	0.000146	CcSEcCtD
Quinapril—Syncope—Epirubicin—hematologic cancer	5.48e-05	0.000146	CcSEcCtD
Quinapril—Back pain—Doxorubicin—hematologic cancer	5.47e-05	0.000145	CcSEcCtD
Quinapril—Constipation—Prednisone—hematologic cancer	5.45e-05	0.000145	CcSEcCtD
Quinapril—Palpitations—Epirubicin—hematologic cancer	5.4e-05	0.000143	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.39e-05	0.00177	CbGpPWpGaD
Quinapril—Loss of consciousness—Epirubicin—hematologic cancer	5.37e-05	0.000143	CcSEcCtD
Quinapril—Dizziness—Triamcinolone—hematologic cancer	5.34e-05	0.000142	CcSEcCtD
Quinapril—Cough—Epirubicin—hematologic cancer	5.33e-05	0.000142	CcSEcCtD
Quinapril—Anaphylactic shock—Methotrexate—hematologic cancer	5.33e-05	0.000142	CcSEcCtD
Quinapril—Infection—Methotrexate—hematologic cancer	5.3e-05	0.000141	CcSEcCtD
Quinapril—Nausea—Etoposide—hematologic cancer	5.29e-05	0.00014	CcSEcCtD
Quinapril—Feeling abnormal—Prednisone—hematologic cancer	5.26e-05	0.00014	CcSEcCtD
Quinapril—Asthenia—Dexamethasone—hematologic cancer	5.26e-05	0.00014	CcSEcCtD
Quinapril—Asthenia—Betamethasone—hematologic cancer	5.26e-05	0.00014	CcSEcCtD
Quinapril—Ill-defined disorder—Doxorubicin—hematologic cancer	5.25e-05	0.000139	CcSEcCtD
Quinapril—Nervous system disorder—Methotrexate—hematologic cancer	5.23e-05	0.000139	CcSEcCtD
Quinapril—Thrombocytopenia—Methotrexate—hematologic cancer	5.22e-05	0.000139	CcSEcCtD
Quinapril—Gastrointestinal pain—Prednisone—hematologic cancer	5.22e-05	0.000138	CcSEcCtD
Quinapril—Nausea—Prednisolone—hematologic cancer	5.21e-05	0.000138	CcSEcCtD
Quinapril—Myalgia—Epirubicin—hematologic cancer	5.2e-05	0.000138	CcSEcCtD
Quinapril—Arthralgia—Epirubicin—hematologic cancer	5.2e-05	0.000138	CcSEcCtD
Quinapril—Chest pain—Epirubicin—hematologic cancer	5.2e-05	0.000138	CcSEcCtD
Quinapril—Pruritus—Betamethasone—hematologic cancer	5.18e-05	0.000138	CcSEcCtD
Quinapril—Pruritus—Dexamethasone—hematologic cancer	5.18e-05	0.000138	CcSEcCtD
Quinapril—Skin disorder—Methotrexate—hematologic cancer	5.18e-05	0.000137	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.17e-05	0.000137	CcSEcCtD
Quinapril—Hyperhidrosis—Methotrexate—hematologic cancer	5.15e-05	0.000137	CcSEcCtD
Quinapril—Discomfort—Epirubicin—hematologic cancer	5.14e-05	0.000137	CcSEcCtD
Quinapril—Vomiting—Triamcinolone—hematologic cancer	5.13e-05	0.000136	CcSEcCtD
Quinapril—Malaise—Doxorubicin—hematologic cancer	5.1e-05	0.000135	CcSEcCtD
Quinapril—Rash—Triamcinolone—hematologic cancer	5.09e-05	0.000135	CcSEcCtD
Quinapril—Dry mouth—Epirubicin—hematologic cancer	5.09e-05	0.000135	CcSEcCtD
Quinapril—Dermatitis—Triamcinolone—hematologic cancer	5.09e-05	0.000135	CcSEcCtD
Quinapril—Vertigo—Doxorubicin—hematologic cancer	5.08e-05	0.000135	CcSEcCtD
Quinapril—Syncope—Doxorubicin—hematologic cancer	5.07e-05	0.000135	CcSEcCtD
Quinapril—Headache—Triamcinolone—hematologic cancer	5.06e-05	0.000134	CcSEcCtD
Quinapril—Abdominal pain—Prednisone—hematologic cancer	5.04e-05	0.000134	CcSEcCtD
Quinapril—Diarrhoea—Betamethasone—hematologic cancer	5.01e-05	0.000133	CcSEcCtD
Quinapril—Diarrhoea—Dexamethasone—hematologic cancer	5.01e-05	0.000133	CcSEcCtD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	5.01e-05	0.00165	CbGpPWpGaD
Quinapril—Palpitations—Doxorubicin—hematologic cancer	5e-05	0.000133	CcSEcCtD
Quinapril—Oedema—Epirubicin—hematologic cancer	4.99e-05	0.000132	CcSEcCtD
Quinapril—Anaphylactic shock—Epirubicin—hematologic cancer	4.99e-05	0.000132	CcSEcCtD
Quinapril—Loss of consciousness—Doxorubicin—hematologic cancer	4.97e-05	0.000132	CcSEcCtD
Quinapril—Infection—Epirubicin—hematologic cancer	4.96e-05	0.000132	CcSEcCtD
Quinapril—Cough—Doxorubicin—hematologic cancer	4.94e-05	0.000131	CcSEcCtD
Quinapril—Shock—Epirubicin—hematologic cancer	4.91e-05	0.00013	CcSEcCtD
Quinapril—Nervous system disorder—Epirubicin—hematologic cancer	4.89e-05	0.00013	CcSEcCtD
Quinapril—Thrombocytopenia—Epirubicin—hematologic cancer	4.88e-05	0.00013	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.87e-05	0.0016	CbGpPWpGaD
Quinapril—Tachycardia—Epirubicin—hematologic cancer	4.87e-05	0.000129	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.86e-05	0.000129	CcSEcCtD
Quinapril—Skin disorder—Epirubicin—hematologic cancer	4.85e-05	0.000129	CcSEcCtD
Quinapril—Dizziness—Betamethasone—hematologic cancer	4.84e-05	0.000129	CcSEcCtD
Quinapril—Dizziness—Dexamethasone—hematologic cancer	4.84e-05	0.000129	CcSEcCtD
Quinapril—Hyperhidrosis—Epirubicin—hematologic cancer	4.82e-05	0.000128	CcSEcCtD
Quinapril—Insomnia—Methotrexate—hematologic cancer	4.82e-05	0.000128	CcSEcCtD
Quinapril—Myalgia—Doxorubicin—hematologic cancer	4.82e-05	0.000128	CcSEcCtD
Quinapril—Chest pain—Doxorubicin—hematologic cancer	4.82e-05	0.000128	CcSEcCtD
Quinapril—Arthralgia—Doxorubicin—hematologic cancer	4.82e-05	0.000128	CcSEcCtD
Quinapril—Nausea—Triamcinolone—hematologic cancer	4.79e-05	0.000127	CcSEcCtD
Quinapril—Paraesthesia—Methotrexate—hematologic cancer	4.79e-05	0.000127	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.78e-05	0.000127	CcSEcCtD
Quinapril—Discomfort—Doxorubicin—hematologic cancer	4.76e-05	0.000126	CcSEcCtD
Quinapril—Dyspnoea—Methotrexate—hematologic cancer	4.75e-05	0.000126	CcSEcCtD
Quinapril—Somnolence—Methotrexate—hematologic cancer	4.74e-05	0.000126	CcSEcCtD
Quinapril—Dry mouth—Doxorubicin—hematologic cancer	4.71e-05	0.000125	CcSEcCtD
Quinapril—Dyspepsia—Methotrexate—hematologic cancer	4.69e-05	0.000125	CcSEcCtD
Quinapril—Vomiting—Dexamethasone—hematologic cancer	4.66e-05	0.000124	CcSEcCtD
Quinapril—Vomiting—Betamethasone—hematologic cancer	4.66e-05	0.000124	CcSEcCtD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	4.65e-05	0.00153	CbGpPWpGaD
Quinapril—Rash—Betamethasone—hematologic cancer	4.62e-05	0.000123	CcSEcCtD
Quinapril—Rash—Dexamethasone—hematologic cancer	4.62e-05	0.000123	CcSEcCtD
Quinapril—Anaphylactic shock—Doxorubicin—hematologic cancer	4.62e-05	0.000123	CcSEcCtD
Quinapril—Oedema—Doxorubicin—hematologic cancer	4.62e-05	0.000123	CcSEcCtD
Quinapril—Dermatitis—Dexamethasone—hematologic cancer	4.61e-05	0.000122	CcSEcCtD
Quinapril—Dermatitis—Betamethasone—hematologic cancer	4.61e-05	0.000122	CcSEcCtD
Quinapril—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.6e-05	0.000122	CcSEcCtD
Quinapril—Fatigue—Methotrexate—hematologic cancer	4.6e-05	0.000122	CcSEcCtD
Quinapril—Headache—Dexamethasone—hematologic cancer	4.59e-05	0.000122	CcSEcCtD
Quinapril—Headache—Betamethasone—hematologic cancer	4.59e-05	0.000122	CcSEcCtD
Quinapril—Infection—Doxorubicin—hematologic cancer	4.59e-05	0.000122	CcSEcCtD
Quinapril—Asthenia—Prednisone—hematologic cancer	4.58e-05	0.000122	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.55e-05	0.000121	CcSEcCtD
Quinapril—Shock—Doxorubicin—hematologic cancer	4.54e-05	0.000121	CcSEcCtD
Quinapril—Nervous system disorder—Doxorubicin—hematologic cancer	4.53e-05	0.00012	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.52e-05	0.00149	CbGpPWpGaD
Quinapril—Thrombocytopenia—Doxorubicin—hematologic cancer	4.52e-05	0.00012	CcSEcCtD
Quinapril—Pruritus—Prednisone—hematologic cancer	4.51e-05	0.00012	CcSEcCtD
Quinapril—Insomnia—Epirubicin—hematologic cancer	4.51e-05	0.00012	CcSEcCtD
Quinapril—Tachycardia—Doxorubicin—hematologic cancer	4.51e-05	0.00012	CcSEcCtD
Quinapril—Skin disorder—Doxorubicin—hematologic cancer	4.48e-05	0.000119	CcSEcCtD
Quinapril—Paraesthesia—Epirubicin—hematologic cancer	4.48e-05	0.000119	CcSEcCtD
Quinapril—Hyperhidrosis—Doxorubicin—hematologic cancer	4.46e-05	0.000118	CcSEcCtD
Quinapril—Dyspnoea—Epirubicin—hematologic cancer	4.45e-05	0.000118	CcSEcCtD
Quinapril—Somnolence—Epirubicin—hematologic cancer	4.44e-05	0.000118	CcSEcCtD
Quinapril—Feeling abnormal—Methotrexate—hematologic cancer	4.39e-05	0.000117	CcSEcCtD
Quinapril—Dyspepsia—Epirubicin—hematologic cancer	4.39e-05	0.000117	CcSEcCtD
Quinapril—Diarrhoea—Prednisone—hematologic cancer	4.36e-05	0.000116	CcSEcCtD
Quinapril—Gastrointestinal pain—Methotrexate—hematologic cancer	4.36e-05	0.000116	CcSEcCtD
Quinapril—Nausea—Dexamethasone—hematologic cancer	4.35e-05	0.000116	CcSEcCtD
Quinapril—Nausea—Betamethasone—hematologic cancer	4.35e-05	0.000116	CcSEcCtD
Quinapril—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.31e-05	0.000114	CcSEcCtD
Quinapril—Fatigue—Epirubicin—hematologic cancer	4.3e-05	0.000114	CcSEcCtD
Quinapril—Constipation—Epirubicin—hematologic cancer	4.27e-05	0.000113	CcSEcCtD
Quinapril—Dizziness—Prednisone—hematologic cancer	4.22e-05	0.000112	CcSEcCtD
Quinapril—Abdominal pain—Methotrexate—hematologic cancer	4.21e-05	0.000112	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.21e-05	0.000112	CcSEcCtD
Quinapril—Insomnia—Doxorubicin—hematologic cancer	4.18e-05	0.000111	CcSEcCtD
Quinapril—Paraesthesia—Doxorubicin—hematologic cancer	4.15e-05	0.00011	CcSEcCtD
Quinapril—Dyspnoea—Doxorubicin—hematologic cancer	4.12e-05	0.000109	CcSEcCtD
Quinapril—Feeling abnormal—Epirubicin—hematologic cancer	4.11e-05	0.000109	CcSEcCtD
Quinapril—Somnolence—Doxorubicin—hematologic cancer	4.1e-05	0.000109	CcSEcCtD
Quinapril—Gastrointestinal pain—Epirubicin—hematologic cancer	4.08e-05	0.000108	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.07e-05	0.00134	CbGpPWpGaD
Quinapril—Dyspepsia—Doxorubicin—hematologic cancer	4.06e-05	0.000108	CcSEcCtD
Quinapril—Vomiting—Prednisone—hematologic cancer	4.06e-05	0.000108	CcSEcCtD
Quinapril—Rash—Prednisone—hematologic cancer	4.02e-05	0.000107	CcSEcCtD
Quinapril—Dermatitis—Prednisone—hematologic cancer	4.02e-05	0.000107	CcSEcCtD
Quinapril—Headache—Prednisone—hematologic cancer	4e-05	0.000106	CcSEcCtD
Quinapril—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.99e-05	0.000106	CcSEcCtD
Quinapril—Fatigue—Doxorubicin—hematologic cancer	3.98e-05	0.000106	CcSEcCtD
Quinapril—ACE—Metabolism of proteins—CCL2—hematologic cancer	3.98e-05	0.00131	CbGpPWpGaD
Quinapril—Constipation—Doxorubicin—hematologic cancer	3.95e-05	0.000105	CcSEcCtD
Quinapril—Abdominal pain—Epirubicin—hematologic cancer	3.94e-05	0.000105	CcSEcCtD
Quinapril—Asthenia—Methotrexate—hematologic cancer	3.82e-05	0.000102	CcSEcCtD
Quinapril—Feeling abnormal—Doxorubicin—hematologic cancer	3.8e-05	0.000101	CcSEcCtD
Quinapril—Nausea—Prednisone—hematologic cancer	3.79e-05	0.000101	CcSEcCtD
Quinapril—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.77e-05	0.0001	CcSEcCtD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.77e-05	0.00124	CbGpPWpGaD
Quinapril—Pruritus—Methotrexate—hematologic cancer	3.77e-05	0.0001	CcSEcCtD
Quinapril—Abdominal pain—Doxorubicin—hematologic cancer	3.65e-05	9.69e-05	CcSEcCtD
Quinapril—Diarrhoea—Methotrexate—hematologic cancer	3.65e-05	9.68e-05	CcSEcCtD
Quinapril—Asthenia—Epirubicin—hematologic cancer	3.58e-05	9.5e-05	CcSEcCtD
Quinapril—Pruritus—Epirubicin—hematologic cancer	3.53e-05	9.37e-05	CcSEcCtD
Quinapril—Dizziness—Methotrexate—hematologic cancer	3.53e-05	9.36e-05	CcSEcCtD
Quinapril—Diarrhoea—Epirubicin—hematologic cancer	3.41e-05	9.06e-05	CcSEcCtD
Quinapril—Vomiting—Methotrexate—hematologic cancer	3.39e-05	9e-05	CcSEcCtD
Quinapril—Rash—Methotrexate—hematologic cancer	3.36e-05	8.92e-05	CcSEcCtD
Quinapril—Dermatitis—Methotrexate—hematologic cancer	3.36e-05	8.92e-05	CcSEcCtD
Quinapril—Headache—Methotrexate—hematologic cancer	3.34e-05	8.87e-05	CcSEcCtD
Quinapril—Asthenia—Doxorubicin—hematologic cancer	3.31e-05	8.79e-05	CcSEcCtD
Quinapril—Dizziness—Epirubicin—hematologic cancer	3.3e-05	8.76e-05	CcSEcCtD
Quinapril—Pruritus—Doxorubicin—hematologic cancer	3.27e-05	8.67e-05	CcSEcCtD
Quinapril—Vomiting—Epirubicin—hematologic cancer	3.17e-05	8.42e-05	CcSEcCtD
Quinapril—Nausea—Methotrexate—hematologic cancer	3.17e-05	8.41e-05	CcSEcCtD
Quinapril—Diarrhoea—Doxorubicin—hematologic cancer	3.16e-05	8.38e-05	CcSEcCtD
Quinapril—Rash—Epirubicin—hematologic cancer	3.15e-05	8.35e-05	CcSEcCtD
Quinapril—Dermatitis—Epirubicin—hematologic cancer	3.14e-05	8.34e-05	CcSEcCtD
Quinapril—Headache—Epirubicin—hematologic cancer	3.13e-05	8.3e-05	CcSEcCtD
Quinapril—Dizziness—Doxorubicin—hematologic cancer	3.05e-05	8.1e-05	CcSEcCtD
Quinapril—Nausea—Epirubicin—hematologic cancer	2.96e-05	7.87e-05	CcSEcCtD
Quinapril—Vomiting—Doxorubicin—hematologic cancer	2.93e-05	7.79e-05	CcSEcCtD
Quinapril—Rash—Doxorubicin—hematologic cancer	2.91e-05	7.73e-05	CcSEcCtD
Quinapril—Dermatitis—Doxorubicin—hematologic cancer	2.91e-05	7.72e-05	CcSEcCtD
Quinapril—Headache—Doxorubicin—hematologic cancer	2.89e-05	7.68e-05	CcSEcCtD
Quinapril—Nausea—Doxorubicin—hematologic cancer	2.74e-05	7.28e-05	CcSEcCtD
Quinapril—SLC15A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.72e-05	0.000895	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.54e-05	0.000837	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.52e-05	0.00083	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.36e-05	0.000777	CbGpPWpGaD
